This content is machine translated Biosimilars Exchange with reference preparations possible without problems Biosimilars are inexpensive imitation drugs of expensive biological drugs. Now, Swissmedic has confirmed that the two types of drugs are comparable in terms of efficacy and safety. The Federal Office…
View Post 3 min This content is machine translated Generics market in Switzerland Mepha restructures and looks to 2014 with hope The healthcare system is not only under constant pressure to perform, but also under ever-increasing cost pressure. This also applies to generic drug companies in Switzerland. However, Mepha feels it…
